Clinical Trial Update: Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study [Phase 4]

View source ↗

Summary

A Phase IV feasibility study evaluating whether urinary proteomics can guide early intervention to prevent complications in type 2 diabetes and diabetic nephrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Type 2 DM, Type 2 DM /Diabetic Nephropathy | Phase 4 | Status: ENROLLING_BY_INVITATION